• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单晚服用安慰剂可改善客观失眠患者的睡眠。

Placebo for a single night improves sleep in patients with objective insomnia.

作者信息

Rogev Eldor, Pillar Giora

机构信息

Sleep Laboratory, Rambam Health Care Campus, Haifa, Israel.

出版信息

Isr Med Assoc J. 2013 Aug;15(8):434-8.

PMID:24079065
Abstract

BACKGROUND

Insomnia is the most common sleep disorder. Treatment options are improved sleep hygiene, relaxation, cognitive behavioral therapy, and medications. Studies examining the effect of hypnotics on insomnia reported that placebo had a substantial beneficial effect.

OBJECTIVES

To evaluate whether placebo is an effective treatment for insomnia.

METHODS

We assessed 25 patients with insomnia who were enrolled in a hypnotic study but prior to the study were asked to undergo two full nights in laboratory polysomnography studies: with and without a placebo. Although they were not explicitly told that they were receiving a placebo, the participants knew that the results of these studies would determine whether they met the criteria to participate in the pharmaceutical study.

RESULTS

Although the participants acknowledged that they were given a placebo, almost all measures of their sleep improved. With placebo, sleep latency was shortened from 55.8 +/- 43.5 to 39.8 +/- 58.5 minutes (P < 0.05); total sleep time was extended from 283 +/- 72.5 to 362.9 +/- 56.3 minutes, and sleep efficiency improved from 59.57 +/- 14.78 to 75.5 +/- 11.70% (P < 0.05). Interestingly, placebo had no effect on the relative sleep stage distribution (percentage of total sleep time), except for a trend toward increased percentage of REM sleep.

CONCLUSIONS

Our findings show a clear and significant beneficial effect of placebo on insomnia, despite participants' understanding that they were receiving placebo. These results emphasize the importance of the patients' perception and belief in insomnia treatment, and suggest that in some cases placebo may serve as a treatment.

摘要

背景

失眠是最常见的睡眠障碍。治疗方法包括改善睡眠卫生、放松、认知行为疗法和药物治疗。研究催眠药物对失眠影响的报告指出,安慰剂具有显著的有益效果。

目的

评估安慰剂是否是治疗失眠的有效方法。

方法

我们评估了25名失眠患者,他们参与了一项催眠药物研究,但在研究前被要求在实验室进行两晚的多导睡眠图研究:一晚使用安慰剂,另一晚不使用。尽管未明确告知他们使用的是安慰剂,但参与者知道这些研究结果将决定他们是否符合参与药物研究的标准。

结果

尽管参与者承认他们使用了安慰剂,但几乎所有睡眠指标都有所改善。使用安慰剂时,睡眠潜伏期从55.8±43.5分钟缩短至39.8±58.5分钟(P<0.05);总睡眠时间从283±72.5分钟延长至362.9±56.3分钟,睡眠效率从59.57±14.78%提高至75.5±11.70%(P<0.05)。有趣的是,安慰剂对相对睡眠阶段分布(总睡眠时间的百分比)没有影响,除了快速眼动睡眠百分比有增加的趋势。

结论

我们的研究结果表明,尽管参与者知道自己使用的是安慰剂,但安慰剂对失眠仍有明显且显著的有益效果。这些结果强调了患者对失眠治疗的认知和信念的重要性,并表明在某些情况下安慰剂可能可作为一种治疗方法。

相似文献

1
Placebo for a single night improves sleep in patients with objective insomnia.单晚服用安慰剂可改善客观失眠患者的睡眠。
Isr Med Assoc J. 2013 Aug;15(8):434-8.
2
Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.缬草提取物对睡眠结构和睡眠质量影响的批判性评价。
Pharmacopsychiatry. 2000 Mar;33(2):47-53. doi: 10.1055/s-2000-7972.
3
The effect of placebo administration on the first-night effect in healthy young volunteers.安慰剂给药对健康年轻志愿者首夜效应的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2007 May 9;31(4):839-47. doi: 10.1016/j.pnpbp.2007.01.019. Epub 2007 Jan 31.
4
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.三甲丙咪嗪治疗原发性失眠:一项多导睡眠图双盲对照研究的结果
Pharmacopsychiatry. 2002 Sep;35(5):165-74. doi: 10.1055/s-2002-34119.
5
Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.唑吡坦缓释片的疗效与安全性:一项针对原发性失眠成人患者的双盲、安慰剂对照研究。
Sleep Med. 2006 Aug;7(5):397-406. doi: 10.1016/j.sleep.2006.04.008. Epub 2006 Jul 3.
6
A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.一项评估唑吡坦治疗慢性失眠症的多中心、安慰剂对照研究。
J Clin Psychiatry. 1994 May;55(5):192-9.
7
The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.部分正变构GABA(A)受体调节剂EVT 201在治疗成人原发性失眠患者方面有效且安全。
Sleep Med. 2009 Sep;10(8):859-64. doi: 10.1016/j.sleep.2008.10.005. Epub 2009 Mar 31.
8
A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.一项在原发性失眠的日本患者中进行的随机安慰剂对照多导睡眠图研究:eszopiclone。
Sleep Med. 2012 Dec;13(10):1247-53. doi: 10.1016/j.sleep.2012.08.015. Epub 2012 Oct 11.
9
A polysomnography study of eszopiclone in elderly patients with insomnia.老年失眠患者使用艾司佐匹克隆的多导睡眠图研究。
Curr Med Res Opin. 2006 Sep;22(9):1633-42. doi: 10.1185/030079906X112741.
10
Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.唑吡坦对失眠患者睡眠结构及其次晨残留效应的影响:与溴替唑仑的随机交叉对照研究
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):22-9. doi: 10.1016/j.pnpbp.2005.06.018. Epub 2005 Jul 25.

引用本文的文献

1
Pathobiology of Second-Generation Antihistamines Related to Sleep in Urticaria Patients.第二代抗组胺药与荨麻疹患者睡眠相关的病理生物学
Biology (Basel). 2022 Mar 11;11(3):433. doi: 10.3390/biology11030433.
2
Prescription of Sedative Drugs During Hospital Stay: A Swiss Prospective Study.住院期间镇静药物的处方:一项瑞士前瞻性研究。
Drugs Real World Outcomes. 2017 Dec;4(4):225-234. doi: 10.1007/s40801-017-0117-6.